Announcement • Jun 27

Noble Africa LLC entered into an agreement to acquire ENDRA Life Sciences Inc. (NasdaqCM:NDRA) in a reverse merger transaction.

Noble Africa LLC entered into an agreement to acquire ENDRA Life Sciences Inc. (NasdaqCM:NDRA) in a reverse merger transaction on June 25, 2026. Under the terms of the merger agreement, as of the closing of the Proposed Transactions, ASP Isotopes is expected to own approximately 89% of the combined company, the pre-closing ENDRA stockholders are expected to own approximately 3% of the combined company, and investors in the private placement financing (other than ASPI) are expected to own approximately 7% of the combined company. Upon completion of the Proposed Transactions, the combined company plans to operate under the name Noble Africa Inc. and will apply to trade on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “NOBA.” The combined company will initially be led by Paul Mann, Chief Executive Officer of Renergen and Chief Executive Officer and Executive Chairman of ASP Isotopes, and Nick Mitchell, Chief Operating Officer of Renergen and Co-Chief Operating Officer of ASP Isotopes. The combined company’s Board of Directors will consist of five directors selected by ASP Isotopes, including the Chief Executive Officer of the combined company, four non-executive directors designated by ASP Isotopes and one non-executive director designated by ENDRA. The transaction is subject to ENDRA Life Sciences having a cash equal to, or greater than, $3,800,002.59, approval of offer by ENDRA Life Sciences shareholders, registration statement effectiveness, and listing / approval of new shares on stock exchange. The deal has been unanimously approved by the board. The expected completion of the transaction is in the third or fourth quarter of 2026. Matthew Fry, Rachel O’Donnell, and Simin Sun of Haynes and Boone, LLP acted as legal advisor for Noble Africa LLC. Coleman Wombwell and Patrick Rogers of K&L Gates LLP acted as legal advisor for ENDRA Life Sciences Inc. Lucid Capital Markets, LLC acted as financial advisor for ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. Stock Price

NDRA Share Price Performance

NDRA Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

ENDRA Life Sciences Inc. Key Details

About NDRA

Recent NDRA News & Updates

New major risk - Financial position

Shareholder Rights Law Firm Probes ENDRA Life Sciences Merger with Noble Africa LLC

Noble Africa LLC entered into an agreement to acquire ENDRA Life Sciences Inc. (NasdaqCM:NDRA) in a reverse merger transaction.

Recent updates

ENDRA Life Sciences Inc. Competitors

Concord Medical Services Holdings

Firefly Neuroscience

Exlites Holdings International

Longduoduo